Alkem Laboratories Limited — Updates, 04-02-2025: Press Release

Alkem Laboratories Limited has introduced Kojiglo serum in India, targeting facial hyperpigmentation. This serum is notable for being the first liposomal serum in the country to utilize advanced Duo-Lipo technology, making it suitable for all skin types. Formulated with key ingredients like liposomal azelaic acid and tranexamic acid, Kojiglo serum enhances skin penetration and provides effective results while minimizing sensitivity risks.

Dr. Vikas Gupta, CEO of Alkem, highlighted the prevalent awareness of skin hyperpigmentation among the Indian population, underlining the company's commitment to offering high-quality skincare solutions. With existing products in the demelanising category, including Kojiglo cream and face wash, Alkem aims to expand its market share with this new launch. The serum will be available on prescription, encouraging consultations with dermatologists prior to use.

This product introduction could positively influence Alkem's position in the skincare market, given its ongoing efforts to enhance its product portfolio.